TPST

Tempest Therapeutics
TPST

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$47.78M
EV
$42.16M
Shares Outstanding
4.44M
Beta
-2.31

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$9.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Tempest Therapeutics, Inc.

gainify
TPST

Tempest Therapeutics, Inc.

TPST

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company’s two clinical programs are TPST-1495, a dual antagonist of EP2 and...

Sector

Healthcare

Industry

Biotechnology

CEO

Brady, Stephen

Employees

21

IPO Date

2012-11-12

Headquarters

2000 Sierra Point Parkway, Suite 400, Brisbane, California, 94005, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.